Orphan Drug Development: Overcoming Manufacturing Challenges

Orphan Drug Development: Overcoming Manufacturing Challenges

The Context

Developing medications for rare diseases presents unique manufacturing challenges due to small patient populations and limited commercial volumes.

Specific Challenges

• Very small batch sizes needed
• Limited economies of scale
• Specialized formulation requirements
• Complex regulatory pathway

Strategic Approach

CDMO Selection Criteria

• Experience with small-volume production
• Flexible manufacturing capabilities
• Regulatory expertise in orphan drugs

Manufacturing Strategy

• Dedicated equipment allocation
• Multi-product facility considerations
• Specialized containment for potent compounds

Key Outcomes

• Successfully launched in 12 months
• Cost-effective small-batch production
• Regulatory approvals in US and EU

Insights for Others

1. Partner with CDMOs experienced in orphan drugs
2. Plan for regulatory complexities early
3. Consider long-term supply strategy